Suzanne C Morris

US Patent:

20190365785, Dec 5, 2019

Filed:

Feb 19, 2018

Appl. No.:

16/476608

Inventors:

- Cincinnati OH, US
Suzanne Morris - Mason OH, US
Unni Krishna Sri Rama Lingeswa Samavedam - Cincinnati OH, US
Simon Patrick Hogan - Witmore Lake MI, US

International Classification:

A61K 31/575
A61K 31/155
A61K 31/216
A61K 39/35
A61P 37/08

Abstract:

Provided are methods of preventing or suppressing an allergic reaction to food by administering an inhibitor of the unfolded protein response (UPR) and uses of a composition comprising an inhibitor of the UPR for treating or preventing a food allergy for manufacture of a medicament for treating or preventing a food allergy.

US Patent:

20180000837, Jan 4, 2018

Filed:

Sep 14, 2017

Appl. No.:

15/704097

Inventors:

- Cincinnati OH, US
Marat V. Khodoun - Mason OH, US
Suzanne C. Morris - Mason OH, US

International Classification:

A61K 31/573
A61K 31/506
A61K 45/06
A61K 31/675
A61K 31/4709
A61K 31/4439
A61K 31/4409
A61K 31/335
C07K 16/42
A61K 31/137
A61K 39/00

Abstract:

Methods for suppressing IgE-mediated anaphylaxis are provided herein, which include administering to a person in need thereof a combination of at least two therapeutic agents selected from the group consisting of an antihistamine, one or more beta-adrenergic agonists, and one or more tyrosine kinase antagonists. Also provided herein are methods of suppressing IgE-mediated anaphylaxis associated with immunotherapeutic desensitization of a subject, and pharmaceutical compositions for suppressing IgE-mediated anaphylaxis.

US Patent:

20150246125, Sep 3, 2015

Filed:

Feb 27, 2015

Appl. No.:

14/633305

Inventors:

- Cincinnati OH, US
Marat V. Khodoun - Mason OH, US
Suzanne C. Morris - Mason OH, US

Assignee:

UNIVERSITY OF CINCINNATI - Cincinnati OH

International Classification:

A61K 39/395
A61K 31/675
A61K 31/506
A61K 31/573
A61K 31/137
A61K 31/335
A61K 45/06
A61K 31/4439
A61K 31/4709

Abstract:

Methods for suppressing IgE-mediated anaphylaxis are provided herein, which include administering to a person in need thereof a combination of at least two therapeutic agents selected from the group consisting of an antihistamine, one or more beta-adrenergic agonists, and one or more tyrosine kinase antagonists. Also provided herein are methods of suppressing IgE-mediated anaphylaxis associated with immunotherapeutic desensitization of a subject, and pharmaceutical compositions for suppressing IgE-mediated anaphylaxis.